• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精的首过代谢。晚餐后无昼夜变化及其被西咪替丁抑制的情况。

First-pass metabolism of alcohol. Absence of diurnal variation and its inhibition by cimetidine after evening meal.

作者信息

Sharma R, Gentry R T, Lim R T, Lieber C S

机构信息

GI/Liver Program, Bronx VAMC, New York 10468, USA.

出版信息

Dig Dis Sci. 1995 Oct;40(10):2091-7. doi: 10.1007/BF02208989.

DOI:10.1007/BF02208989
PMID:7587772
Abstract

To determine whether the first-pass metabolism (FPM) of orally consumed alcohol varies with the time of day, 12 healthy male subjects were tested with both oral and intravenous alcohol (0.3 g/kg), in the morning and evening, always 1 hr after the same standard meal. The results revealed no significant differences in FPM (81.6 +/- 11.6 vs 92.8 +/- 10.6 mg/kg) or in any other index of alcohol absorption and metabolism. Eleven subjects were also tested in the evening after treatment with cimetidine, an H2-antagonist that inhibits gastric alcohol dehydrogenase activity in vitro. Compared to baseline, cimetidine (1 g/day for eight days) significantly decreased FPM (from 100.1 +/- 8.0 to 52.6 +/- 11.4 mg/kg, P < 0.01) and increased the systemic bioavailability of alcohol (from 66 +/- 3 to 82 +/- 4%, P < 0.01), as well as peak blood alcohol concentrations (from 4.3 +/- 0.4 to 5.9 +/- 0.5 mM, P < 0.05) and areas under the curve (from 5.1 +/- 0.5 to 7.0 +/- 0.5 mM/hr, P < 0.01). The results indicate the absence of diurnal variation in FPM and suggest that patients given cimetidine should be warned of its possible interaction with alcohol regardless of the time of day.

摘要

为了确定口服酒精的首过代谢(FPM)是否随一天中的时间而变化,12名健康男性受试者在早晨和晚上,均在同一标准餐后1小时接受口服和静脉注射酒精(0.3 g/kg)测试。结果显示,FPM(81.6±11.6 vs 92.8±10.6 mg/kg)或酒精吸收与代谢的任何其他指标均无显著差异。11名受试者还在晚上接受西咪替丁治疗后进行了测试,西咪替丁是一种H2拮抗剂,在体外可抑制胃酒精脱氢酶活性。与基线相比,西咪替丁(1 g/天,共8天)显著降低了FPM(从100.1±8.0降至52.6±11.4 mg/kg,P<0.01),并提高了酒精的全身生物利用度(从66±3%提高到82±4%,P<0.01),以及血中酒精浓度峰值(从4.3±0.4 mM提高到5.9±0.5 mM,P<0.05)和曲线下面积(从5.1±0.5提高到7.0±0.5 mM/hr,P<0.01)。结果表明FPM不存在昼夜变化,并提示无论在一天中的什么时间,接受西咪替丁治疗的患者都应被告知其与酒精可能存在相互作用。

相似文献

1
First-pass metabolism of alcohol. Absence of diurnal variation and its inhibition by cimetidine after evening meal.酒精的首过代谢。晚餐后无昼夜变化及其被西咪替丁抑制的情况。
Dig Dis Sci. 1995 Oct;40(10):2091-7. doi: 10.1007/BF02208989.
2
Effects of ranitidine on blood alcohol levels after ethanol ingestion. Comparison with other H2-receptor antagonists.雷尼替丁对乙醇摄入后血乙醇水平的影响。与其他H2受体拮抗剂的比较。
JAMA. 1992 Jan 1;267(1):83-6.
3
Effects of omeprazole on ethanol metabolism: an in vitro and in vivo rat and human study.奥美拉唑对乙醇代谢的影响:一项大鼠和人体的体内外研究
Pharmacol Res. 1994 Jan-Feb;29(1):47-58. doi: 10.1016/1043-6618(94)80097-9.
4
Omeprazole, ranitidine, and cimetidine have no effect on peak blood ethanol concentrations, first pass metabolism or area under the time-ethanol curve under 'real-life' drinking conditions.在“实际生活”饮酒条件下,奥美拉唑、雷尼替丁和西咪替丁对血液乙醇峰值浓度、首过代谢或乙醇-时间曲线下面积均无影响。
Aliment Pharmacol Ther. 1998 Feb;12(2):141-5. doi: 10.1046/j.1365-2036.1998.00281.x.
5
Significant increase of blood alcohol by cimetidine after repetitive drinking of small alcohol doses.西咪替丁在多次小剂量饮酒后会使血液酒精含量显著升高。
Alcohol Clin Exp Res. 1995 Aug;19(4):1083-7. doi: 10.1111/j.1530-0277.1995.tb00993.x.
6
[Effects of H2-blockers on alcohol dehydrogenase (ADH) activity].[H2受体阻滞剂对乙醇脱氢酶(ADH)活性的影响]
Pol Merkur Lekarski. 2008 Dec;25(150):531-3.
7
Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists has no influence on the pharmacokinetics of ethanol after a moderate dose.组胺H2受体拮抗剂对胃乙醇脱氢酶活性的抑制作用对中等剂量乙醇的药代动力学没有影响。
Br J Clin Pharmacol. 1994 Feb;37(2):208-11. doi: 10.1111/j.1365-2125.1994.tb04263.x.
8
Age and bioavailability of alcohol.
Z Gastroenterol. 2001 Sep;39(9):783-8. doi: 10.1055/s-2001-17196.
9
Cimetidine and ranitidine. Lack of effect on the pharmacokinetics of an acute ethanol dose.
J Clin Gastroenterol. 1993 Oct;17(3):189-94.
10
First-pass metabolism of ethanol is predominantly gastric.乙醇的首过代谢主要发生在胃部。
Alcohol Clin Exp Res. 1993 Dec;17(6):1337-44. doi: 10.1111/j.1530-0277.1993.tb05250.x.

引用本文的文献

1
Lower survival and higher rates of cirrhosis in patients with ROUX-EN-Y gastric bypass hospitalised with alcohol-associated hepatitis.行 Roux-en-Y 胃旁路术的患者因酒精性肝炎住院后,生存率降低,肝硬化发生率升高。
BMJ Open Gastroenterol. 2023 Feb;10(1). doi: 10.1136/bmjgast-2022-001083.
2
Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.变异性在解释乙醇药代动力学中的作用:研究与法医学应用。
Clin Pharmacokinet. 2003;42(1):1-31. doi: 10.2165/00003088-200342010-00001.
3
Effect of histamine-2 receptor antagonists on blood alcohol levels: a meta-analysis.

本文引用的文献

1
Ranitidine has no effect on postbreakfast ethanol absorption.雷尼替丁对早餐后乙醇吸收没有影响。
Am J Gastroenterol. 1993 Feb;88(2):217-21.
2
In vivo uptake of ethanol and release of acetate in rat liver and GI.大鼠肝脏和胃肠道中乙醇的体内摄取及乙酸盐的释放。
Life Sci. 1993;53(10):PL165-70. doi: 10.1016/0024-3205(93)90510-a.
3
Antagonist: the case against first-pass metabolism of ethanol in the stomach.拮抗剂:关于乙醇在胃中首过代谢的反对观点。
组胺-2受体拮抗剂对血液酒精水平的影响:一项荟萃分析。
J Gen Intern Med. 1998 Sep;13(9):594-9. doi: 10.1046/j.1525-1497.1998.00181.x.
4
Pharmacokinetic interactions between alcohol and other drugs.酒精与其他药物之间的药代动力学相互作用。
Clin Pharmacokinet. 1997 Aug;33(2):79-90. doi: 10.2165/00003088-199733020-00001.
5
H2 antagonists and blood alcohol levels.H2拮抗剂与血液酒精水平。
Dig Dis Sci. 1993 Mar;38(3):569-73. doi: 10.1007/BF01316517.
J Lab Clin Med. 1994 Jan;123(1):28-31; discussion 32-3.
4
Agonist: gastric first pass metabolism of alcohol.激动剂:酒精的胃首过代谢。
J Lab Clin Med. 1994 Jan;123(1):21-6; discussion 27.
5
First-pass metabolism of ethanol is predominantly gastric.乙醇的首过代谢主要发生在胃部。
Alcohol Clin Exp Res. 1993 Dec;17(6):1337-44. doi: 10.1111/j.1530-0277.1993.tb05250.x.
6
Review article: lack of clinical significance of the interaction between H2-receptor antagonists and ethanol.综述文章:H2受体拮抗剂与乙醇相互作用缺乏临床意义
Aliment Pharmacol Ther. 1993 Apr;7(2):131-8. doi: 10.1111/j.1365-2036.1993.tb00081.x.
7
Bioavailability of alcohol: role of gastric metabolism and its interaction with other drugs.酒精的生物利用度:胃代谢的作用及其与其他药物的相互作用。
Dig Dis. 1994 Nov-Dec;12(6):351-67. doi: 10.1159/000171470.
8
Significant increase of blood alcohol by cimetidine after repetitive drinking of small alcohol doses.西咪替丁在多次小剂量饮酒后会使血液酒精含量显著升高。
Alcohol Clin Exp Res. 1995 Aug;19(4):1083-7. doi: 10.1111/j.1530-0277.1995.tb00993.x.
9
Ethanol 'dose-dependent' elimination: Michaelis-Menten v classical kinetic analysis.乙醇的“剂量依赖性”消除:米氏动力学与经典动力学分析
Br J Clin Pharmacol. 1981 Nov;12(5):667-73. doi: 10.1111/j.1365-2125.1981.tb01287.x.
10
Meal timing dominates the lighting regimen as a synchronizer of the circadian blood ethanol clearance rate rhythm in rats.
J Nutr. 1981 Nov;111(11):2000-5. doi: 10.1093/jn/111.11.2000.